CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
-$0.01-6.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 03/31/2025 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 76.60K | 36.90K | 23.30K | 212.80K | 621.00K |
| Depreciation & Amortization | 1.70K | 6.40K | 1.60K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.30K | 43.40K | 24.90K | 212.80K | 621.00K |
| Operating Income | -78.30K | -43.40K | -24.90K | -212.80K | -621.00K |
| Income Before Tax | -84.70K | -50.30K | -29.50K | -337.10K | -628.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.70K | -50.30K | -29.50K | -337.10K | -628.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.70K | -50.30K | -29.50K | -337.10K | -628.50K |
| EBIT | -78.30K | -43.40K | -24.90K | -212.80K | -621.00K |
| EBITDA | -76.60K | -41.70K | -23.30K | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.02 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.02 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 59.05M | 58.26M | 56.13M | 19.51M | 19.75M |
| Average Diluted Shares Outstanding | 59.05M | 58.26M | 56.13M | 19.51M | 19.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |